Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | -2.26% | 542.10 | 1.0% | $872.73m | |
| DHR | Danaher Corp. | -2.03% | 243.92 | 0.7% | $751.05m | |
| ABT | Abbott Laboratories | -1.56% | 112.75 | 0.8% | $685.90m | |
| ISRG | Intuitive Surgical, Inc. | -4.37% | 215.35 | 0.8% | $584.23m | |
| MDT | Medtronic Plc | -2.38% | 103.73 | 0.6% | $526.36m | |
| BSX | Boston Scientific Corp. | -2.69% | 40.21 | 1.0% | $414.30m | |
| SYK | Stryker Corp. | -2.84% | 232.35 | 1.3% | $390.11m | |
| ALGN | Align Technology, Inc. | -4.09% | 269.11 | 6.4% | $366.94m | |
| BDX | Becton, Dickinson & Co. | -2.10% | 250.89 | 1.0% | $323.71m | |
| IDXX | IDEXX Laboratories, Inc. | -2.47% | 357.33 | 3.8% | $318.18m | |
| EW | Edwards Lifesciences Corp. | -4.04% | 93.46 | 0.4% | $307.77m | |
| DXCM | DexCom, Inc. | -7.13% | 308.49 | 7.7% | $262.77m | |
| A | Agilent Technologies, Inc. | -1.78% | 120.89 | 1.6% | $247.78m | |
| BAX | Baxter International, Inc. | -2.92% | 72.17 | 1.8% | $241.01m | |
| MTD | Mettler-Toledo International, Inc. | -3.27% | 1196.00 | 5.8% | $180.96m |
Company Profile
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.